In the current report, we present 24 patients with intrahepatic bile duct dilation and no mass lesion demonstrated on US or CT who underwent resectional treatment under the diagnosis of presumed ...

The clinical picture and course in all these cases were associated with histologic evidence of intrahepatic cholestasis. Only patients with clinical evidence of jaundice and a serum bilirubin ...

The development of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt insertion, especially within 30 ...

Researchers from Universidad del País Vasco and affiliated organizations presented data from a study that aimed to investigate the role of macrophage receptor with collagenous structure (MARCO) in ...

AdventHealth Tampa is the first in the Tampa Bay area to offer a powerful new pump-based treatment option for colorectal ...

Mirum Pharmaceuticals’ MIRM lead product, Livmarli (maralixibat), an orally administered ileal bile acid transporter (“IBAT”) ...

HUTCHMED has announced the completion of patient enrollment in a Phase II trial for fanregratinib (HMPL-453), aimed at treating intrahepatic cholangiocarcinoma (IHCC) patients with FGFR2 fusion ...